Skip to main content
. Author manuscript; available in PMC: 2012 Jul 30.
Published in final edited form as: Circ Res. 2010 Jul 29;107(7):913–922. doi: 10.1161/CIRCRESAHA.110.222703

Table 1.

Myocardial Infarct phenotype before and after treatment (values determined by cMRI)

Parameter Groups Baseline Post-MI Week 2 Post-Inj Week 8 Post-Inj p-value
Infarct Size (%LV mass) CCM 0 24.4±3.2 23.5±1.7 26.3±1.5
MSCs 0 24.9±2.4 14.5±3.1 10.9±5.1 p=0.002*
Infarct Volume (ml) CCM 0 13.4±1.3 11.9±1.0 13.4±1.0 p=0.009*
MSCs 0 11.7±1.7 7.7±1.8 7.3±3.5 p≤0.001
LV mass (g) CCM 51.2±3.3 51.2±3.3 51.7±5.0 51.5±6.0
MSCs 45.9±3.6 45.9±3.6 51.2±4.2 62.1±5.4 p=NS
Circumferential Extent of MI (%LV) CCM 0 41.5±5.0 44.8±2.4 38.04±4.3
MSCs 0 38.8±4.0 27.8±6.5 27.6±12.1 p=NS
End-Diastolic Volume (ml) CCM 33.2±3.4 38.8±4.0 43.0±4.8 40.5±1.2
MSCs 32.2±2.4 34.2±3.8 41.0±4.7 46.5±10.7 p=NS
End-Systolic Volume (ml) CCM 20.3±2.3 28.9±3.6 30.8±4.1 28.2±0.9
MSCs 20.1±1.6 24.5±2.6 26.7±5.1 31.4±11.3 p=NS
Stroke Volume (ml) CCM 12.9±1.3 9.8±1.1 12.2±0.8 12.2±0.3 p= 0.003
MSCs 12.1±1.0 9.7±1.3 14.3±1.4 15.1±1.1 p=0.005
Heart Rate CCM 86.2±6.8 82.2±3.0 69.1±1.5 81.1±19.5
MSCs 102.5±9.0 85.7±4.3 81.0±5.5 84.1±17.3 p=NS
Ejection Fraction CCM 39.1±1.6 25.8±3.1 29.1±1.4 30.2±0.4 p=0.042
MSCs 37.8±1.6 27.9±1.1 37.0±5.0 36.4±9.4 p=0.026
*

indicates p values significant between groups

indicate p values significant within group

indicate p values significant within group